Denmark’s Novo Nordisk and South Africa’s Aspen sign a deal to produce insulin for African patients
Published
Danish pharmaceutical company Novo Nordisk has signed a deal with South Africa’s Aspen Pharmacare to produce human insulin specifically for diabetes patients in Africa where there is a dire need for the life-saving treatment.
#danish #novonordisk #southafricas #aspenpharmacare #africa